A Study of Adavosertib (MK-1775) in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004)
Clinical trial NCT01357161 · COMPLETED
Trial details
- NCT number
- NCT01357161
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-26
- Primary completion
- 2016-08-08
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.